Despite a recent rally, analysts argue Dollar General's defensive business model, deep rural footprint, and focus on essentials position it for steady, long-term growth as a haven for value-conscious investors.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
AbbVie's $2.1 billion acquisition of Capstan Therapeutics signals a strategic pivot towards next-generation immunology treatments. The move aims to secure future revenue streams as the company navigates the post-Humira era, with analysts highlighting the transformative potential of its in vivo CAR-T platform.
Stride, Inc., a leading provider of K-12 online education, has seen its stock price pressured by temporary operational challenges. However, a closer look reveals a fundamentally sound business trading at a significant discount to its historical valuation, with a robust recurring revenue model and a substantial share buyback program underway.
Often overshadowed by flashier tech names, glass and materials science giant Corning has secured a multi-year, $6 billion agreement with Meta Platforms to supply optical fiber for AI data centers, positioning itself as a critical but under-the-radar beneficiary of the infrastructure build-out.
Once a high-flying adtech darling, The Trade Desk has seen its stock crater nearly 80% from its peak amid a fierce battle with Amazon's ad juggernaut. With shares now trading at a significant discount to the market, analysts are divided on whether this marks a historic buying opportunity or signals deeper structural challenges.
Elon Musk consolidates his space and artificial intelligence ventures, with SpaceX acquiring xAI to form a private sector titan valued over a trillion dollars, aiming to solve AI's energy crisis by moving compute to space.
DaVita Inc. reported Q4 2025 results in line with expectations, highlighting a milestone first profitable year for its Integrated Kidney Care unit. While revenue per treatment accelerated, the company continues to face pressure from elevated patient mortality and rising benefit costs. Executives provided 2026 guidance projecting mid-single-digit operating income growth and a sharp rise in EPS, buoyed by share buybacks and the stabilization of prior investment losses.
Fabrinet's fiscal Q2 2026 results smashed expectations, fueled by explosive growth in data center interconnect modules and a breakout performance in high-performance computing. The manufacturing services provider raises guidance, signaling strong momentum across its key markets.
Simon Property Group reported robust fourth-quarter results, driven by record funds from operations and resilient leasing demand. The retail REIT giant is steering a multi-billion dollar redevelopment strategy while returning significant capital to shareholders, even as it navigates a cautious outlook for 2026.
Simon Property Group reported robust fourth-quarter and full-year 2025 results, highlighted by record funds from operations, $2 billion in strategic acquisitions, and a significant return of capital to shareholders. The retail REIT giant provided optimistic 2026 guidance, banking on a strong development pipeline and resilient tenant demand despite acknowledging tariff-related headwinds.
Elon Musk consolidates his AI and aerospace ambitions by merging SpaceX with xAI, a move driven by a radical vision to power next-generation artificial intelligence from space.
Woodward, Inc. (WWD) kicked off fiscal 2026 with robust first-quarter results, driven by exceptional performance in commercial aerospace services and broad-based industrial growth. The company reported a 29% year-over-year sales increase and a 54% jump in EPS, prompting an upward revision to its annual guidance.
Kforce reports stronger-than-expected Q4 2025 results, citing the highest sequential growth in its tech business since 2022. The company sees early signs of a market recovery, fueled by client demand for flexible talent to tackle AI-driven projects and foundational IT work.
Shares of Huntington Bancshares (HBAN) have climbed over 17% in the past 90 days, closing recently at $17.88. This rally has investors scrutinizing whether the regional bank's stock still holds value after its strong run, with some models suggesting a significant upside to fair value.
Despite a challenging year for its stock price, a deep dive into Hess Midstream's financials suggests the midstream operator may be significantly undervalued. Our analysis examines the cash flow story behind the recent share price weakness and what it means for investors.
A recent adjustment to Ceres Power Holdings' price target by analysts signals a broader reassessment of the clean energy firm's market narrative and future trajectory, moving beyond a single figure to underlying story shifts.
Brunswick Corporation (NYSE:BC) delivered robust fourth-quarter results, driven by strength across all segments, particularly its propulsion business. While management expressed optimism for 2026, the company's accelerated share repurchases have sparked a fresh debate among analysts regarding its valuation and the sustainability of its current momentum.
Shares of New York-focused REIT Alexander's have delivered impressive returns, but a closer look reveals a widening gap between its market price and key valuation metrics, prompting debate among investors.
Polaris Inc. shares have surged over 55% in the past year, but a recent pullback has investors questioning whether the powersports leader remains a buy. Conflicting signals from valuation models paint a complex picture for the iconic brand.
